BioXcel Therapeutics Investor Relations Material
Latest events
Q4 2023
BioXcel Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from BioXcel Therapeutics Inc
Access all reports
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's primary product candidate, UB-311, utilizes unique artificial intelligence-based technology platforms to identify new indications for existing drugs and to uncover new applications for combinatorial therapeutics.
Key slides for BioXcel Therapeutics Inc
R&D Day 2023
BioXcel Therapeutics Inc
R&D Day 2023
BioXcel Therapeutics Inc
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States